All 12 Quarter Horses have been placed on the Steward's List meaning they cannot run in any licensed jurisdiction in North America until the adjudication process has been finalized. Both trainers were ...
We think Biogen's neurology, immunology, and focus on rare diseases support a narrow moat. Biogen's strategy has its roots in the 2003 merger of Biogen (Avonex for treating multiple sclerosis, or MS) ...